aluates Reports

$ 0.0

Automative

Global Mental Illness Drugs Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-6N11546

Global Mental Illness Drugs Market Research Report 2022

BUY CHAPTERS

Global Mental Illness Drugs Market Research Report 2024

Code: QYRE-Auto-6N11546

Report

January 2024

Pages:77

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Johnson and Johnson

Pfizer Inc

Eli Lilly

GlaxoSmithKline PLC

Astrazeneca plc

Bristol–Myers Squibb

Mental Illness Drugs Market Size

The global Mental Illness Drugs market was valued at US$ 1546 million in 2023 and is anticipated to reach US$ 2277.7 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.

Mental Illness Drugs Market

Mental Illness is a psychological anomaly that is reflected in patient’s behavior through disability, distress, or any conduct that is not considered as normal mental development. The causes of mental lllness are very diverse and often unclear in most cases.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Mental Illness Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mental Illness Drugs.

Report Scope

The Mental Illness Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mental Illness Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Mental Illness Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Mental Illness Drugs Market Report

Report Metric	Details
Report Name	Mental Illness Drugs Market
Accounted market size in 2023	US$ 1546 million
Forecasted market size in 2030	US$ 2277.7 million
CAGR	5.8%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Antipsychotics Antidepressants Antianxiety (anxiolyitcs) Anti-seizure medications Stimulants Cognitive disorders and dementia Sleep disorder treatments Substance abuse treatments
Segment by Application	Hospital Clinic Drugstore
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Johnson and Johnson, Pfizer, Eli Lilly, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mental Illness Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mental Illness Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Mental Illness Drugs Market growing?

Ans: The Mental Illness Drugs Market witnessing a CAGR of 5.8% during the forecast period 2024-2030.

What is the Mental Illness Drugs Market size in 2030?

Ans: The Mental Illness Drugs Market size in 2030 will be US$ 2277.7 million.

Who are the main players in the Mental Illness Drugs Market report?

Ans: The main players in the Mental Illness Drugs Market are Johnson and Johnson, Pfizer, Eli Lilly, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb

What are the Application segmentation covered in the Mental Illness Drugs Market report?

Ans: The Applications covered in the Mental Illness Drugs Market report are Hospital, Clinic, Drugstore

What are the Type segmentation covered in the Mental Illness Drugs Market report?

Ans: The Types covered in the Mental Illness Drugs Market report are Antipsychotics, Antidepressants, Antianxiety (anxiolyitcs), Anti-seizure medications, Stimulants, Cognitive disorders and dementia, Sleep disorder treatments, Substance abuse treatments

1 Mental Illness Drugs Market Overview

1.1 Product Overview and Scope of Mental Illness Drugs

1.2 Mental Illness Drugs Segment by Type

1.2.1 Global Mental Illness Drugs Market Value Comparison by Type (2024-2030)

1.2.2 Antipsychotics

1.2.3 Antidepressants

1.2.4 Antianxiety (anxiolyitcs)

1.2.5 Anti-seizure medications

1.2.6 Stimulants

1.2.7 Cognitive disorders and dementia

1.2.8 Sleep disorder treatments

1.2.9 Substance abuse treatments

1.3 Mental Illness Drugs Segment by Application

1.3.1 Global Mental Illness Drugs Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Drugstore

1.4 Global Mental Illness Drugs Market Size Estimates and Forecasts

1.4.1 Global Mental Illness Drugs Revenue 2019-2030

1.4.2 Global Mental Illness Drugs Sales 2019-2030

1.4.3 Global Mental Illness Drugs Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Mental Illness Drugs Market Competition by Manufacturers

2.1 Global Mental Illness Drugs Sales Market Share by Manufacturers (2019-2024)

2.2 Global Mental Illness Drugs Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Mental Illness Drugs Average Price by Manufacturers (2019-2024)

2.4 Global Mental Illness Drugs Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Mental Illness Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Mental Illness Drugs, Product Type & Application

2.7 Mental Illness Drugs Market Competitive Situation and Trends

2.7.1 Mental Illness Drugs Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Mental Illness Drugs Players Market Share by Revenue

2.7.3 Global Mental Illness Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Mental Illness Drugs Retrospective Market Scenario by Region

3.1 Global Mental Illness Drugs Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Mental Illness Drugs Global Mental Illness Drugs Sales by Region: 2019-2030

3.2.1 Global Mental Illness Drugs Sales by Region: 2019-2024

3.2.2 Global Mental Illness Drugs Sales by Region: 2025-2030

3.3 Global Mental Illness Drugs Global Mental Illness Drugs Revenue by Region: 2019-2030

3.3.1 Global Mental Illness Drugs Revenue by Region: 2019-2024

3.3.2 Global Mental Illness Drugs Revenue by Region: 2025-2030

3.4 North America Mental Illness Drugs Market Facts & Figures by Country

3.4.1 North America Mental Illness Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Mental Illness Drugs Sales by Country (2019-2030)

3.4.3 North America Mental Illness Drugs Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Mental Illness Drugs Market Facts & Figures by Country

3.5.1 Europe Mental Illness Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Mental Illness Drugs Sales by Country (2019-2030)

3.5.3 Europe Mental Illness Drugs Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Mental Illness Drugs Market Facts & Figures by Country

3.6.1 Asia Pacific Mental Illness Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Mental Illness Drugs Sales by Country (2019-2030)

3.6.3 Asia Pacific Mental Illness Drugs Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Mental Illness Drugs Market Facts & Figures by Country

3.7.1 Latin America Mental Illness Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Mental Illness Drugs Sales by Country (2019-2030)

3.7.3 Latin America Mental Illness Drugs Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Mental Illness Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Mental Illness Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Mental Illness Drugs Sales by Country (2019-2030)

3.8.3 Middle East and Africa Mental Illness Drugs Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Mental Illness Drugs Sales by Type (2019-2030)

4.1.1 Global Mental Illness Drugs Sales by Type (2019-2024)

4.1.2 Global Mental Illness Drugs Sales by Type (2025-2030)

4.1.3 Global Mental Illness Drugs Sales Market Share by Type (2019-2030)

4.2 Global Mental Illness Drugs Revenue by Type (2019-2030)

4.2.1 Global Mental Illness Drugs Revenue by Type (2019-2024)

4.2.2 Global Mental Illness Drugs Revenue by Type (2025-2030)

4.2.3 Global Mental Illness Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Mental Illness Drugs Price by Type (2019-2030)

5 Segment by Application

5.1 Global Mental Illness Drugs Sales by Application (2019-2030)

5.1.1 Global Mental Illness Drugs Sales by Application (2019-2024)

5.1.2 Global Mental Illness Drugs Sales by Application (2025-2030)

5.1.3 Global Mental Illness Drugs Sales Market Share by Application (2019-2030)

5.2 Global Mental Illness Drugs Revenue by Application (2019-2030)

5.2.1 Global Mental Illness Drugs Revenue by Application (2019-2024)

5.2.2 Global Mental Illness Drugs Revenue by Application (2025-2030)

5.2.3 Global Mental Illness Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Mental Illness Drugs Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Johnson and Johnson

6.1.1 Johnson and Johnson Corporation Information

6.1.2 Johnson and Johnson Description and Business Overview

6.1.3 Johnson and Johnson Mental Illness Drugs Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Johnson and Johnson Mental Illness Drugs Product Portfolio

6.1.5 Johnson and Johnson Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Corporation Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Mental Illness Drugs Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Pfizer Mental Illness Drugs Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 Eli Lilly

6.3.1 Eli Lilly Corporation Information

6.3.2 Eli Lilly Description and Business Overview

6.3.3 Eli Lilly Mental Illness Drugs Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Eli Lilly Mental Illness Drugs Product Portfolio

6.3.5 Eli Lilly Recent Developments/Updates

6.4 GlaxoSmithKline

6.4.1 GlaxoSmithKline Corporation Information

6.4.2 GlaxoSmithKline Description and Business Overview

6.4.3 GlaxoSmithKline Mental Illness Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 GlaxoSmithKline Mental Illness Drugs Product Portfolio

6.4.5 GlaxoSmithKline Recent Developments/Updates

6.5 AstraZeneca

6.5.1 AstraZeneca Corporation Information

6.5.2 AstraZeneca Description and Business Overview

6.5.3 AstraZeneca Mental Illness Drugs Sales, Revenue and Gross Margin (2019-2024)

6.5.4 AstraZeneca Mental Illness Drugs Product Portfolio

6.5.5 AstraZeneca Recent Developments/Updates

6.6 Bristol-Myers Squibb

6.6.1 Bristol-Myers Squibb Corporation Information

6.6.2 Bristol-Myers Squibb Description and Business Overview

6.6.3 Bristol-Myers Squibb Mental Illness Drugs Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Bristol-Myers Squibb Mental Illness Drugs Product Portfolio

6.6.5 Bristol-Myers Squibb Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Mental Illness Drugs Industry Chain Analysis

7.2 Mental Illness Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Mental Illness Drugs Production Mode & Process

7.4 Mental Illness Drugs Sales and Marketing

7.4.1 Mental Illness Drugs Sales Channels

7.4.2 Mental Illness Drugs Distributors

7.5 Mental Illness Drugs Customers

8 Mental Illness Drugs Market Dynamics

8.1 Mental Illness Drugs Industry Trends

8.2 Mental Illness Drugs Market Drivers

8.3 Mental Illness Drugs Market Challenges

8.4 Mental Illness Drugs Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Johnson and Johnson

Pfizer Inc

Eli Lilly

GlaxoSmithKline PLC

Astrazeneca plc

Bristol–Myers Squibb

List of Tables

Table 1. Global Mental Illness Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Mental Illness Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Mental Illness Drugs Market Competitive Situation by Manufacturers in 2023

Table 4. Global Mental Illness Drugs Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Mental Illness Drugs Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Mental Illness Drugs Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Mental Illness Drugs Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Mental Illness Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Mental Illness Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Mental Illness Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Mental Illness Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Mental Illness Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Mental Illness Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mental Illness Drugs as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Mental Illness Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Mental Illness Drugs Sales by Region (2019-2024) & (K Units)

Table 18. Global Mental Illness Drugs Sales Market Share by Region (2019-2024)

Table 19. Global Mental Illness Drugs Sales by Region (2025-2030) & (K Units)

Table 20. Global Mental Illness Drugs Sales Market Share by Region (2025-2030)

Table 21. Global Mental Illness Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Mental Illness Drugs Revenue Market Share by Region (2019-2024)

Table 23. Global Mental Illness Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Mental Illness Drugs Revenue Market Share by Region (2025-2030)

Table 25. North America Mental Illness Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Mental Illness Drugs Sales by Country (2019-2024) & (K Units)

Table 27. North America Mental Illness Drugs Sales by Country (2025-2030) & (K Units)

Table 28. North America Mental Illness Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Mental Illness Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Mental Illness Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Mental Illness Drugs Sales by Country (2019-2024) & (K Units)

Table 32. Europe Mental Illness Drugs Sales by Country (2025-2030) & (K Units)

Table 33. Europe Mental Illness Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Mental Illness Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Mental Illness Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Mental Illness Drugs Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Mental Illness Drugs Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Mental Illness Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Mental Illness Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Mental Illness Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Mental Illness Drugs Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Mental Illness Drugs Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Mental Illness Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Mental Illness Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Mental Illness Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Mental Illness Drugs Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Mental Illness Drugs Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Mental Illness Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Mental Illness Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Mental Illness Drugs Sales (K Units) by Type (2019-2024)

Table 51. Global Mental Illness Drugs Sales (K Units) by Type (2025-2030)

Table 52. Global Mental Illness Drugs Sales Market Share by Type (2019-2024)

Table 53. Global Mental Illness Drugs Sales Market Share by Type (2025-2030)

Table 54. Global Mental Illness Drugs Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Mental Illness Drugs Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Mental Illness Drugs Revenue Market Share by Type (2019-2024)

Table 57. Global Mental Illness Drugs Revenue Market Share by Type (2025-2030)

Table 58. Global Mental Illness Drugs Price (USD/Unit) by Type (2019-2024)

Table 59. Global Mental Illness Drugs Price (USD/Unit) by Type (2025-2030)

Table 60. Global Mental Illness Drugs Sales (K Units) by Application (2019-2024)

Table 61. Global Mental Illness Drugs Sales (K Units) by Application (2025-2030)

Table 62. Global Mental Illness Drugs Sales Market Share by Application (2019-2024)

Table 63. Global Mental Illness Drugs Sales Market Share by Application (2025-2030)

Table 64. Global Mental Illness Drugs Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Mental Illness Drugs Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Mental Illness Drugs Revenue Market Share by Application (2019-2024)

Table 67. Global Mental Illness Drugs Revenue Market Share by Application (2025-2030)

Table 68. Global Mental Illness Drugs Price (USD/Unit) by Application (2019-2024)

Table 69. Global Mental Illness Drugs Price (USD/Unit) by Application (2025-2030)

Table 70. Johnson and Johnson Corporation Information

Table 71. Johnson and Johnson Description and Business Overview

Table 72. Johnson and Johnson Mental Illness Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Johnson and Johnson Mental Illness Drugs Product

Table 74. Johnson and Johnson Recent Developments/Updates

Table 75. Pfizer Corporation Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer Mental Illness Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Pfizer Mental Illness Drugs Product

Table 79. Pfizer Recent Developments/Updates

Table 80. Eli Lilly Corporation Information

Table 81. Eli Lilly Description and Business Overview

Table 82. Eli Lilly Mental Illness Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Eli Lilly Mental Illness Drugs Product

Table 84. Eli Lilly Recent Developments/Updates

Table 85. GlaxoSmithKline Corporation Information

Table 86. GlaxoSmithKline Description and Business Overview

Table 87. GlaxoSmithKline Mental Illness Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. GlaxoSmithKline Mental Illness Drugs Product

Table 89. GlaxoSmithKline Recent Developments/Updates

Table 90. AstraZeneca Corporation Information

Table 91. AstraZeneca Description and Business Overview

Table 92. AstraZeneca Mental Illness Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. AstraZeneca Mental Illness Drugs Product

Table 94. AstraZeneca Recent Developments/Updates

Table 95. Bristol-Myers Squibb Corporation Information

Table 96. Bristol-Myers Squibb Description and Business Overview

Table 97. Bristol-Myers Squibb Mental Illness Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Bristol-Myers Squibb Mental Illness Drugs Product

Table 99. Bristol-Myers Squibb Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. Mental Illness Drugs Distributors List

Table 103. Mental Illness Drugs Customers List

Table 104. Mental Illness Drugs Market Trends

Table 105. Mental Illness Drugs Market Drivers

Table 106. Mental Illness Drugs Market Challenges

Table 107. Mental Illness Drugs Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Mental Illness Drugs

Figure 2. Global Mental Illness Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Mental Illness Drugs Market Share by Type in 2023 & 2030

Figure 4. Antipsychotics Product Picture

Figure 5. Antidepressants Product Picture

Figure 6. Antianxiety (anxiolyitcs) Product Picture

Figure 7. Anti-seizure medications Product Picture

Figure 8. Stimulants Product Picture

Figure 9. Cognitive disorders and dementia Product Picture

Figure 10. Sleep disorder treatments Product Picture

Figure 11. Substance abuse treatments Product Picture

Figure 12. Global Mental Illness Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 13. Global Mental Illness Drugs Market Share by Application in 2023 & 2030

Figure 14. Hospital

Figure 15. Clinic

Figure 16. Drugstore

Figure 17. Global Mental Illness Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 18. Global Mental Illness Drugs Market Size (2019-2030) & (US$ Million)

Figure 19. Global Mental Illness Drugs Sales (2019-2030) & (K Units)

Figure 20. Global Mental Illness Drugs Average Price (USD/Unit) & (2019-2030)

Figure 21. Mental Illness Drugs Report Years Considered

Figure 22. Mental Illness Drugs Sales Share by Manufacturers in 2023

Figure 23. Global Mental Illness Drugs Revenue Share by Manufacturers in 2023

Figure 24. The Global 5 and 10 Largest Mental Illness Drugs Players: Market Share by Revenue in 2023

Figure 25. Mental Illness Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 26. Global Mental Illness Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 27. North America Mental Illness Drugs Sales Market Share by Country (2019-2030)

Figure 28. North America Mental Illness Drugs Revenue Market Share by Country (2019-2030)

Figure 29. U.S. Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Canada Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Europe Mental Illness Drugs Sales Market Share by Country (2019-2030)

Figure 32. Europe Mental Illness Drugs Revenue Market Share by Country (2019-2030)

Figure 33. Germany Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. France Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. U.K. Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Italy Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Russia Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Asia Pacific Mental Illness Drugs Sales Market Share by Region (2019-2030)

Figure 39. Asia Pacific Mental Illness Drugs Revenue Market Share by Region (2019-2030)

Figure 40. China Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Japan Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. South Korea Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. India Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Australia Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Taiwan Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Indonesia Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Thailand Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Malaysia Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Philippines Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Latin America Mental Illness Drugs Sales Market Share by Country (2019-2030)

Figure 51. Latin America Mental Illness Drugs Revenue Market Share by Country (2019-2030)

Figure 52. Mexico Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Brazil Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Argentina Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Middle East & Africa Mental Illness Drugs Sales Market Share by Country (2019-2030)

Figure 56. Middle East & Africa Mental Illness Drugs Revenue Market Share by Country (2019-2030)

Figure 57. Turkey Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. Saudi Arabia Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 59. U.A.E Mental Illness Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 60. Global Sales Market Share of Mental Illness Drugs by Type (2019-2030)

Figure 61. Global Revenue Market Share of Mental Illness Drugs by Type (2019-2030)

Figure 62. Global Mental Illness Drugs Price (USD/Unit) by Type (2019-2030)

Figure 63. Global Sales Market Share of Mental Illness Drugs by Application (2019-2030)

Figure 64. Global Revenue Market Share of Mental Illness Drugs by Application (2019-2030)

Figure 65. Global Mental Illness Drugs Price (USD/Unit) by Application (2019-2030)

Figure 66. Mental Illness Drugs Value Chain

Figure 67. Mental Illness Drugs Production Process

Figure 68. Channels of Distribution (Direct Vs Distribution)

Figure 69. Distributors Profiles

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions